Review article: Coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 9, 2013, Pages 1038-1044

  Yesil, A ^a   Yilmaz, Y ^b,c  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; CLINICAL RESEARCH; COFFEE; COHORT ANALYSIS; EMBASE; EXPERIMENTAL ANIMAL; HUMAN; MEDLINE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCIENCE DIRECT; SCOPUS;

ANIMALS; COFFEE; FATTY LIVER; HUMANS; METABOLIC SYNDROME X; PREVALENCE; RESEARCH DESIGN; RISK;

EID: 84885174102     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12489     Document Type: Article

References (45)

1. Butt MS, Sultan MT,. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr 2011; 51: 363-73.
2. Tunnicliffe JM, Erdman KA, Reimer RA, Lun V, Shearer J,. Consumption of dietary caffeine and coffee in physically active populations: physiological interactions. Appl Physiol Nutr Metab 2008; 33: 1301-10.
3. Cadden IS, Partovi N, Yoshida EM,. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 2007; 26: 1-8.
4. Cornelis MC,. Coffee intake. Prog Mol Biol Transl Sci 2012; 108: 293-322.
5. Higdon JV, Frei B,. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006; 46: 101-23.
6. Farinati F, Cardin R, Piciocchi M,. Coffee, chronic diseases and cancer. Eur J Clin Nutr 2013; 67: 898.
7. Cano-Marquina A, Tarín JJ, Cano A,. The impact of coffee on health. Maturitas 2013; 75: 7-21.
8. Dõrea JG, da Costa TH,. Is coffee a functional food? Br J Nutr 2005; 93: 773-82. (Pubitemid 43899553)
9. Ratnayake WM, Hollywood R, O'Grady E, Stavric B,. Lipid content and composition of coffee brews prepared by different methods. Food Chem Toxicol 1993; 31: 263-9. (Pubitemid 23122367)
10. Glade MJ,. Caffeine-Not just a stimulant. Nutrition 2010; 26: 932-8.
11. Sato Y, Itagaki S, Kurokawa T, et al,. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int J Pharm 2011; 403: 136-8.
12. Jung UJ, Lee MK, Park YB, Jeon SM, Choi MS,. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther 2006; 318: 476-83.
13. Lee KJ, Jeong HG,. Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage. Toxicol Lett 2007; 173: 80-7. (Pubitemid 47371047)
14. Lam LK, Sparnins VL, Wattenberg LW,. Effects of derivatives of kahweol and cafestol on the activity of glutathione S-transferase in mice. J Med Chem 1987; 30: 1399-403. (Pubitemid 17114818)
15. Anese M, Nicoli MC,. Antioxidant properties of ready-to-drink coffee brews. J Agric Food Chem 2003; 51: 942-6.
16. Ranheim T, Halvorsen B,. Coffee consumption and human health-beneficial or detrimental? Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 2005; 49: 274-84. (Pubitemid 40445558)
17. Fukushima Y, Kasuga M, Nakao K, Shimomura I, Matsuzawa Y,. Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets. J Agric Food Chem 2009; 57: 11100-5.
18. Panchal SK, Poudyal H, Waanders J, Brown L,. Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J Nutr 2012; 142: 690-7.
19. Abrahão SA, Pereira RG, de Sousa RV, et al,. Influence of coffee brew in metabolic syndrome and type 2 diabetes. Plant Foods Hum Nutr 2013; 68: 184-9.
20. Yamauchi R, Kobayashi M, Matsuda Y, et al,. Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice. J Agric Food Chem 2010; 58: 5597-603.
21. Murase T, Misawa K, Minegishi Y, et al,. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab 2011; 300: E122-33.
22. Vitaglione P, Morisco F, Mazzone G, et al,. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010; 52: 1652-61.
23. Matsuda Y, Kobayashi M, Yamauchi R, et al,. Coffee and caffeine improve insulin sensitivity and glucose tolerance in C57BL/6J mice fed a high-fat diet. Biosci Biotechnol Biochem 2011; 75: 2309-15.
24. Choi EY, Cho YO,. Interaction of physical trainings and coffee intakes in fuel utilization during exercise in rats. Nutr Res Pract 2013; 7: 178-84.
25. Hino A, Adachi H, Enomoto M, et al,. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 2007; 76: 383-9. (Pubitemid 46482724)
26. Driessen MT, Koppes LL, Veldhuis L, Samoocha D, Twisk JW,. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr 2009; 63: 536-42.
27. Balk L, Hoekstra T, Twisk J,. Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol 2009; 24: 203-9.
28. Matsuura H, Mure K, Nishio N, et al,. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol 2012; 22: 160-6.
29. Takami H, Nakamoto M, Uemura H, et al,. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol 2013; 23: 12-20.
30. Mure K, Maeda S, Mukoubayashi C, et al,. Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin. Nutrition 2013; 29: 982-7.
31. Catalano D, Martines GF, Tonzuso A, et al,. Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 2010; 55: 3200-6.
32. Anty R, Marjoux S, Iannelli A, et al,. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 2012; 57: 1090-6.
33. Molloy JW, Calcagno CJ, Williams CD, et al,. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012; 55: 429-36.
34. Gutiérrez-Grobe Y, Chávez-Tapia N, Sánchez-Valle V, et al,. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. Ann Hepatol 2012; 11: 350-5.
35. Birerdinc A, Stepanova M, Pawloski L, Younossi ZM,. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012; 35: 76-82.
36. Matsuzawa Y,. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005; 12: 301.
37. Grundy SM, Brewer HB Jr, Cleeman JI, et al,. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8. (Pubitemid 38133916)
38. Ucar F, Sezer S, Erdogan S, et al,. The relationship between oxidative stress and nonalcoholic fatty liver disease: its effects on the development of nonalcoholic steatohepatitis. Redox Rep 2013; 18: 127-33.
39. Rolo AP, Teodoro JS, Palmeira CM,. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012; 52: 59-69.
40. Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R,. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006; 83: 1039-46. (Pubitemid 44713102)
41. Shim SG, Jun DW, Kim EK, et al,. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J Gastroenterol Hepatol 2013; doi: 10.1111/jgh.12317 [Epub ahead of print].
42. Arauz J, Moreno MG, Cortés-Reynosa P, Salazar EP, Muriel P,. Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage. J Appl Toxicol 2012; 33: 970-9.
43. Ruhl CE, Everhart JE,. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128: 24-32. (Pubitemid 40039955)
44. Honjo S, Kono S, Coleman MP, et al,. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001; 54: 823-9. (Pubitemid 32722187)
45. Grimes DA, Schulz KF,. Bias and causal associations in observational research. Lancet 2002; 359: 248-52. (Pubitemid 34113828)